Eric Walker added Combination therapy trialled as effective against highly drug-resistant tuberculosis (XDR- and MDR-TB), historically a hard-to-treat condition: in 90% of patients (n=109) the disease had resolved and was absent at 6 months after end of treatment, which used three oral drugs over 26 weeks : science to 2020-03 Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Eric Walker added Treatment of Highly Drug-Resistant Pulmonary Tuberculosis and Combination therapy trialled as effective against highly drug-resistant tuberculosis (XDR- and MDR-TB), historically a hard-to-treat condition: in 90% of patients (n=109) the disease had resolved and was absent at 6 months after end of treatment, which used three oral drugs over 26 weeks : science to Treatment of Highly Drug-Resistant Pulmonary Tuberculosis, and added Treatment of Highly Drug-Resistant Pulmonary Tuberculosis to Extensively drug-resistant tuberculosis (XDR-TB)
Eric Walker added LAM4/KZN, 2019-08 FDA approves Pretomanid Tablets in combination with bedaquiline and linezolid for treatment of XDR-TB and 2020-03 Treatment of Highly Drug-Resistant Pulmonary Tuberculosis and a number of links to Extensively drug-resistant tuberculosis (XDR-TB), and added Extensively drug-resistant tuberculosis (XDR-TB) to Multidrug-resistant tuberculosis (MDR-TB), Fluoroquinolones and Extensively drug-resistant (XDR) bacteria